Gynecology
Intratumoral microvessel images shed light on ovarian cancer progression
Published in Women's Health Weekly, November 10th, 2005
According to researchers in Italy, "we previously reported that tumor microvessel density (MVD) may have prognostic significance in ovarian carcinoma."
"The aim of this study was to compare the intratumoral microvessels using a computer-aided image analysis system between FIGO stage IIIC, serous, G3, ovarian carcinomas obtained from living patients who had no evident disease 5 years after primary treatment and ovarian carcinomas, matched for stage, histopathology, grade of differentiation, and treatment, obtained from patients who had died of progression of disease no later...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Cancer Risk Factors
Parental consanguinity in Arabs not associated with higher risk of breast cancer - HIV/AIDS Transmission
Planned caesarian section is safe and effective for preventing transmission of HIV - Menopause
Testosterone therapy improves sexual function in post-menopausal women - Ovarian Cancer
Twelve cohort studies indicate risk of ovarian cancer not linked to fruit and vegetable diet - Type 2 Diabetes
Visceral adipose tissue and type 2 diabetes highest among Filipino women - Alcohol Use
Prenatal exposure to alcohol may cause visual problems in infants - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
